Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LY 3541860

Next Previous
Drug Profile

LY 3541860

Alternative Names: CD19 antibody - Eli Lilly and Company; LY-3541860

Latest Information Update: 13 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Eli Lilly and Company
  • Class Monoclonal antibodies
  • Mechanism of Action CD19 antigen modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Multiple sclerosis; Rheumatoid arthritis
  • Phase I Autoimmune disorders

Most Recent Events

  • 19 Mar 2025 Phase-II clinical trials in Rheumatoid arthritis (In adults, In the elderly, Treatment-experienced) in USA (IV) (NCT06859294)
  • 12 Mar 2025 Eli Lilly and Company plans phase-II trial for Rheumatoid arthritis (Treatment-experienced, In adults, In the elderly) in USA (IV) in March 2025 (NCT06859294),
  • 31 Dec 2024 Phase-I development is ongoing in Japan (SC, IV) (Eli Lilly and Company website, December 2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top